During the past decade, South Sacramento Cancer Center conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 21 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 14 clinical trials were completed. i.e. 73.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Sacramento Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 30 trials, followed by "NRG Oncology" with 12 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored and "Radiation Therapy Oncology Group" with 7 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Sacramento Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 41 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "South Sacramento Cancer Center" are "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials), "Prostate Cancer" (4 trials), "Stage II Breast Cancer" (4 trials), "Stage IIIA Breast Cancer" (4 trials) and "Gliosarcoma" (3 trials). Many other conditions were trialed in "South Sacramento Cancer Center" in a lesser frequency.

Most popular intervention types in "South Sacramento Cancer Center" are "Drug" (52 trials), "Other" (40 trials), "Biological" (27 trials), "Radiation" (27 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (18 trials), "Cisplatin" (12 trials), "Questionnaire Administration" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "South Sacramento Cancer Center" are 56 trials for "All" genders, 9 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "South Sacramento Cancer Center". undefined are not yet recruiting, 21 are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in South Sacramento Cancer Center, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in South Sacramento Cancer Center, 1 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".